Literature DB >> 15259066

Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO.

Tao Wang1, Fei Chen, Zhe Chen, Yi-Feng Wu, Xiao-Li Xu, Shu Zheng, Xun Hu.   

Abstract

AIM: To investigate the signal pathway of honokiol-induced apoptosis on human colorectal carcinoma RKO cells and to evaluate whether p53 and p53-related genes were involved in honokiol-treated RKO cells.
METHODS: Cell cycle distribution and subdiploid peak were analyzed with a flow cytometer and DNA fragment with electrophoresis on agarose gels. Transcriptional level of Bax, Bcl-2, Bid and Bcl-xl was accessed by RT-PCR. Western blotting was used to measure p53 protein expression and other factors related to apoptosis. Proliferation inhibition of two cell lines (RKO, SW480) with high expression of p53 and one cell line with p53 negative expression (LS180) was monitored by MTT assay.
RESULTS: Honokiol induced RKO cell apoptosis in a dose-dependent manner. The mRNA expression level and protein level of Bid were up-regulated while that of Bcl-xl was down-regulated, but no changes in Bax and Bcl-2 were observed. Western blotting showed p53 expression had no remarkable changes in honokiol-induced RKO cell apoptosis. LS180 cells treated with honokiol exhibited apparent growth inhibition like RKO cells and Sw480 cells.
CONCLUSION: Honokiol can induce RKO cells apoptosis through activating caspase cascade by p53-indepenent pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259066      PMCID: PMC4724979          DOI: 10.3748/wjg.v10.i15.2205

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

2.  Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells.

Authors:  Shu Er Yang; Ming Tsuen Hsieh; Tung Hu Tsai; Shih Lan Hsu
Journal:  Biochem Pharmacol       Date:  2002-05-01       Impact factor: 5.858

3.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

4.  Down-regulation of bcl-2 by p53 in breast cancer cells.

Authors:  S Haldar; M Negrini; M Monne; S Sabbioni; C M Croce
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

5.  Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro.

Authors:  H Nagase; K Ikeda; Y Sakai
Journal:  Planta Med       Date:  2001-11       Impact factor: 3.352

6.  Caspase-9 can be activated without proteolytic processing.

Authors:  H R Stennicke; Q L Deveraux; E W Humke; J C Reed; V M Dixit; G S Salvesen
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

7.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

Authors:  T Miyashita; S Krajewski; M Krajewska; H G Wang; H K Lin; D A Liebermann; B Hoffman; J C Reed
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

8.  Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.

Authors:  M Selvakumaran; H K Lin; T Miyashita; H G Wang; S Krajewski; J C Reed; B Hoffman; D Liebermann
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

9.  Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells.

Authors:  T Hirano; M Gotoh; K Oka
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

10.  p53 status and the efficacy of cancer therapy in vivo.

Authors:  S W Lowe; S Bodis; A McClatchey; L Remington; H E Ruley; D E Fisher; D E Housman; T Jacks
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

View more
  29 in total

1.  In vitro growth inhibition of human cancer cells by novel honokiol analogs.

Authors:  Jyh Ming Lin; A S Prakasha Gowda; Arun K Sharma; Shantu Amin
Journal:  Bioorg Med Chem       Date:  2012-04-03       Impact factor: 3.641

2.  Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles.

Authors:  MaLing Gou; XiuLing Zheng; Ke Men; Juan Zhang; BiLan Wang; Lei Lv; XiuHong Wang; YinLan Zhao; Feng Luo; LiJuan Chen; Xia Zhao; YuQuan Wei; ZhiYong Qian
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

Review 3.  Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents.

Authors:  Mélanie Poivre; Pierre Duez
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

4.  Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.

Authors:  Dimiter B Avtanski; Arumugam Nagalingam; Michael Y Bonner; Jack L Arbiser; Neeraj K Saxena; Dipali Sharma
Journal:  Mol Oncol       Date:  2014-01-15       Impact factor: 6.603

5.  Honokiol induces cell cycle arrest and apoptosis in human gastric carcinoma MGC-803 cell line.

Authors:  Bin Yan; Zhi-Yong Peng
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer.

Authors:  Hong Luo; Qian Zhong; Li-juan Chen; Xiao-rong Qi; A-fu Fu; Han-shuo Yang; Fan Yang; Hong-gang Lin; Yu-quan Wei; Xia Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-19       Impact factor: 4.553

7.  4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.

Authors:  N J Lee; J H Oh; J O Ban; J H Shim; H P Lee; J K Jung; B W Ahn; D Y Yoon; S B Han; Y W Ham; J T Hong
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

8.  Honokiol induces cell cycle arrest and apoptosis via p53 activation in H4 human neuroglioma cells.

Authors:  Yun-Bao Guo; Xin-Jie Bao; Song-Bai Xu; Xing-Dong Zhang; Hai-Yan Liu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 9.  Honokiol: a novel natural agent for cancer prevention and therapy.

Authors:  S Arora; S Singh; G A Piazza; C M Contreras; J Panyam; A P Singh
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

Review 10.  Honokiol, a multifunctional antiangiogenic and antitumor agent.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.